News

BioCryst Pharmaceuticals Sets Stage for Key Investor Presentations

BioCryst Pharmaceuticals Sets Stage for Key Investor Presentations

Upcoming Investor Conferences for BioCryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) has made a significant announcement regarding its participation in a series of important investor conferences. These events offer an excellent opportunity for the company to showcase its innovative therapies and engage with the investment community.

Conference Details

The company plans to present at two notable conferences:

TD Cowen Annual Health Care Conference

The first conference is the TD Cowen 45th Annual Health Care Conference, scheduled for a date in early March. During this event, BioCryst will highlight its progress and developments at 9:10 a.m. ET on March 5, 2025. This conference plays a crucial role in allowing the company to connect with health care investors and industry peers.

Barclays Global Healthcare Conference

Following this, BioCryst will also be participating in the Barclays 27th Annual Global Healthcare Conference. This conference is set to take place on March 11, 2025, at 10:00 a.m. ET. At this event, stakeholders can expect insights into the company's future plans and advancements in their therapeutic pipeline.

Accessing Presentations

Investors and interested parties will be able to access the live audio webcasts and subsequent replays of the presentations through the Investors & Media section of BioCryst’s official website. This accessibility ensures that stakeholders can stay informed about the latest developments and strategic directions taken by the company.

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals is a pioneering biotechnology company dedicated to enhancing the lives of individuals affected by rare diseases, particularly those involving complement-mediated conditions. The company's approach centers around utilizing structure-guided drug design techniques to develop both first-in-class and best-in-class therapeutics.

Currently, BioCryst is proud to have commercialized ORLADEYO (berotralstat), which is recognized as the first oral, once-daily plasma kallikrein inhibitor. This innovative treatment represents a significant advancement for patients requiring effective and accessible therapies. Additionally, BioCryst is advancing a robust pipeline consisting of small-molecule and protein therapies that promise to address various challenging medical needs.

Company Contact Information

If you wish to learn more about BioCryst Pharmaceuticals, you can reach out directly to John Bluth, who can be contacted at +1 919 859 7910 or via email at jbluth@biocryst.com.

Frequently Asked Questions

What is the purpose of the upcoming investor conferences?

The investor conferences provide BioCryst an opportunity to share its latest developments, engage with the investment community, and highlight its innovative therapies.

When is BioCryst presenting at the TD Cowen Conference?

BioCryst will present at the TD Cowen 45th Annual Health Care Conference on March 5, 2025, at 9:10 a.m. ET.

Where can investors access the presentation webcasts?

Investors can access the live audio webcasts and replays in the Investors & Media section of BioCryst’s official website.

What is BioCryst's main therapeutic focus?

BioCryst focuses on developing therapies for rare diseases, especially those related to complement-mediated conditions, utilizing innovative drug design techniques.

Who can I contact for more information about BioCryst?

You can contact John Bluth at +1 919 859 7910 or via email at jbluth@biocryst.com for more information regarding the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

New Senior Care Location Opens in Broward County

Updated Category News Views 197

A Personal Mission Driving Business in Hollywood Dive deep into any community, and you'll often find stories that tug at the heartstrings—especially when they're about family. That's the case with Saudia Sital, a Broward County local who's just opened Always Best Care Senior Services in Hollywood, Florida. Her journey from personal caregiver to business owner isn't just...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 117

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Matthew Callstrom Named CEO: Mayo Clinic's Next Era

Updated Category News Views 129

Leadership Change at Mayo Clinic: A Turning Point The Mayo Clinic, a titan in healthcare lands, is on the cusp of a major leadership switch-up. As the trustees hand the reins to Dr. Matthew R. Callstrom, they're banking on a rich blend of experience and visionary thinking to steer their ship. We're looking at what this change might spell for Mayo's storied mission. Who is...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 65

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 106

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 162

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 144

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
Lavazza 2027 Calendar: Moments of Pleasure Worldwide

Updated Category News Views 248

Capturing Fleeting Joy Through the Lens In 2027, Lavazza sets the stage for an evocative exploration of human pleasure through its iconic calendar. Teaming up with photographers Jim Goldberg, Alex Majoli, and Paolo Pellegrin, the project spans three vibrant cities: New York, Lisbon, and Hong Kong. These masters of the lens invite us to pause and appreciate the understated...

Continue Reading
TruGreen Finds New Growth in Birch Hill Acquisition

Updated Category News Views 186

TruGreen's New Chapter Begins In the world of lawn care, TruGreen is sowing the seeds for a revitalized future, courtesy of its recent acquisition by Birch Hill Equity Partners. Based out of Franklin, Tennessee, this powerhouse in the green arena is set to start a fresh chapter, swapping partners like old gloves after a long, 19-year stint with Clayton, Dubilier & Rice...

Continue Reading

Top 5 Most Recently Viewed Articles

David Lord Steps In as New CEO of WorkforceQA, Eric Quilter Moves Up

Updated Category News Views 658

David Lord Takes the Helm as WorkforceQA's New CEO WorkforceQA is excited to welcome David Lord as its new Chief Executive Officer. With a strong history of leadership and a substantial track record of driving growth, David is set to guide the company in providing top-tier compliance and screening solutions. Transition of Leadership In this significant shift, current CEO...

Continue Reading
VARON Champions Environmental Sustainability with Innovative Solutions

Updated Category News Views 323

VARON Champions Environmental Sustainability in Respiratory Care This Earth Day, VARON is proudly reinforcing its commitment to respiratory health and environmental responsibility. As a renowned leader in oxygen concentrator technology, the company remains dedicated to promoting sustainable innovation by offering eco-friendly alternatives to traditional oxygen delivery...

Continue Reading
Revolutionizing AIoT: Hikvision's Launch of Guanlan Models

Updated Category News Views 369

Innovative Launch of Guanlan Large-Scale AI Models Hikvision has officially unveiled its latest advancement in technology with the introduction of Guanlan Large-Scale AI Models. This suite of sophisticated machine learning engines has been meticulously pre-trained using extensive industry knowledge, allowing them to excel across various domains such as computer vision,...

Continue Reading
EssilorLuxottica's Record Shareholding Milestones Showcase Growth

Updated Category News Views 247

EssilorLuxottica’s Remarkable Growth in Employee Shareholding EssilorLuxottica, a global leader in eyewear and optical solutions, is experiencing significant growth, particularly in its employee shareholding initiatives. With nearly 100,000 internal shareholders spread across 85 countries, the company is witnessing an unprecedented level of engagement and investment...

Continue Reading
Exploring the Growth of the Global Medical Equipment Maintenance Market

Updated Category News Views 440

Understanding the Medical Equipment Maintenance Market The medical equipment maintenance market is poised for remarkable growth in the upcoming years. Experts forecast that this market is expected to witness a significant increase, estimated at USD 51.2 billion between 2024 and 2028. This growth reflects a compound annual growth rate (CAGR) of 13.64%, showcasing an...

Continue Reading